Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Researchers worry that Medicaid home care eligibility decisions are often made without public scrutiny and based less on ...
Telehealth companies that have seized on the boom in weight loss drugs are playing a bigger role not just in treating ...
TrumpRx and a most-favored nation policy won’t lower prices for patients, writes the CEO and co-founder of I-MAK.
The Food and Drug Administration on Thursday delivered a split decision on a blood cancer drug from GSK, approving its use in ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
The Food and Drug Administration yesterday delivered a split decision on GSK’s blood cancer drug Blenrep, approving its use ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
WASHINGTON — The Trump administration’s push to make in vitro fertilization more affordable is changing the outlook and ...
Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback